Treatment
Treatment clinical trials
We’re tracking 8,312 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07669207RecruitingPhase 4
Extended azithromycin for early water breaking
This study tests whether giving the antibiotic azithromycin for a longer period can help prevent infections in pregnant people whose water breaks early (between 22 and 28 weeks). If you are staying in the hospital for monitoring, this treatment aims to keep you and your baby healthier for as long as possible before delivery.
Pittsburgh, PennsylvaniaAges Any age - NCT07664683Recruiting
How changing your cancer pill's appearance affects your treatment
This study looks at how switching from a brand-name cancer pill to a generic version (or between two generics) affects your daily routine, ability to stay on treatment, and overall well-being. If you've been on one of these specific pills for at least 6 months and recently made a switch, the researchers want to learn from your experience.
San Juan, AlicanteAges 18 years+ - NCT06673771Recruiting
Vestibular rehab for balance and fatigue after stroke
This trial tests if exercises that target the inner ear's balance system can help people recovering from a stroke improve their balance and reduce tiredness. It may be a good fit if you have trouble with balance and feel very fatigued after your stroke.
Mānsehra, Khyber PakhtunkhuwaAges 30–65 - NCT06673498RecruitingPhase 2
Two drugs to raise platelets before surgery in liver disease
This trial tests two medications (lusutrombopag and recombinant human thrombopoietin) given together to raise platelet levels before a planned surgery in people with chronic liver disease. The goal is to reduce the need for platelet transfusions and make the procedure safer.
Fuyang, AnhuiAges 18 years+ - NCT06023186Recruiting
Effect of mavacamten on heart blood flow in HCM
This study tests whether the drug mavacamten (Camzyos) improves blood flow in the heart's small vessels for people with obstructive hypertrophic cardiomyopathy. You will take mavacamten as prescribed and have a PET/CT scan to measure your heart's blood flow reserve.
Charlottesville, VirginiaAges 18–85 - NCT06341764RecruitingPhase 2
Chemo-immunotherapy before surgery for bile duct cancer
This trial tests a combination of chemotherapy and immunotherapy before surgery for locally advanced bile duct cancer. The goal is to see if this approach can shrink the tumor enough to improve surgical outcomes.
Naples, ItaliaAges 18 years+ - NCT06676410RecruitingPhase 2
Testing Codivir plus standard HIV treatment in new patients
This trial tests a new investigational drug called Codivir added to standard HIV treatment for people who have never taken HIV medications before. It aims to see if adding Codivir helps control the virus better and is safe.
São PauloAges 18 years+ - NCT05321875RecruitingPhase 3
Candesartan to prevent heart failure in certain gene carriers
This trial tests whether candesartan (a blood-pressure medicine) can delay or prevent heart muscle weakening in people who carry a disease-causing dilated cardiomyopathy gene variant but still have fairly strong heart pumping. Participants are randomly assigned to candesartan or a placebo to see which one keeps the heart healthier over time.
Majadahonda, MadridAges 18–64 - NCT06618638Recruiting
Shared Decision Tool for ADPKD Treatment
This study helps people with ADPKD and moderate kidney damage decide together with their doctor whether to start a treatment called tolvaptan. It tests a shared decision-making tool to see if it helps patients understand their options better.
Anyang-si, Gyeonggi-doAges 18–80 - NCT07658417Enrolling by invitation
Once-weekly insulin study for type 2 diabetes
This study tests whether switching from daily basal insulin to once-weekly insulin icodec improves blood sugar control, treatment satisfaction, and how well people stick with the new insulin. It may be a good option if you have type 2 diabetes and are already using a daily basal insulin.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07658651Recruiting
Plug for type B aortic dissection repair
This trial tests a special plug (WeFlow-EndoSeal) placed into the false channel of a type B aortic dissection to help seal it. It is for people who are already getting a stent-graft and aims to improve the repair.
Beijing, Beijing MunicipalityAges 18–80 - NCT07655076RecruitingEarly Phase 1
Smart insulin delivery study for type 1 diabetes
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Toronto, OntarioAges 18 years+ - NCT06678282Recruiting
Testing an investigational cell therapy for B-cell lymphoma or leukemia
This trial tests a new cell therapy (JY231) for people with B-cell lymphoma or B-cell acute lymphoblastic leukemia (B-ALL) that has come back or didn't respond to previous treatments. The therapy targets a marker on cancer cells called CD19 and aims to help your body fight the cancer.
Zhenzhou, HenanAges 18–75 - NCT07662655RecruitingEarly Phase 1
PADN for pulmonary hypertension after mitral valve repair
This study tests a new procedure called pulmonary artery denervation (PADN) to lower high blood pressure in the lungs that persists after a mitral valve repair. It aims to see if this extra treatment improves symptoms and outcomes for people with this condition.
Xiamen, FujianAges 18–80 - NCT07657325Recruiting
Toripalimab for high-risk kidney cancer that has been removed
This trial tests whether the drug toripalimab can prevent kidney cancer from coming back in people who have had their kidney and any visible metastases surgically removed. It focuses on patients with high-risk features or who had some metastatic spots taken out completely.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07662369RecruitingPhase 1/Phase 2
A trial of special immune cells for viral infections after transplant
This trial tests whether specially prepared donor immune cells can fight stubborn viral infections that did not get better with standard treatment. It is for people who have had a stem cell transplant and are still struggling with viruses like CMV, EBV, or others.
Shanghai, SHAges Any age - NCT07656116RecruitingPhase 1
Oncolytic virus therapy for advanced solid tumors
This trial tests a virus-based treatment for people with advanced solid tumors that haven't responded to standard treatments. The virus is designed to infect and kill cancer cells while leaving healthy cells alone.
Langfang, HebeiAges 18 years+ - NCT07657949Recruiting
Nerve block for pain after breast reduction surgery
This trial tests a specific nerve block to see if it can reduce pain after breast reduction surgery, possibly helping with recovery and lowering the need for strong painkillers.
Sivas, SivasAges 18–65 - NCT07661901Recruiting
Reward sensitivity app for teens with suicidal thoughts
This trial tests a smartphone-based program designed to help teens who have had recent thoughts of suicide. It aims to see if the app can reduce suicide risk by boosting sensitivity to rewards in daily life.
Philadelphia, PennsylvaniaAges 13–17 - NCT07660146Recruiting
Predicting extraction needs for orthodontic treatment
This trial tests a method to help dentists decide if you need tooth extractions before braces. Researchers will look at dental models to see if this analysis tool is accurate.
Cairo, Giza GovernorateAges 12 years+ - NCT07657858Recruiting
Does Dry Eye Treatment Affect Astigmatism Measurements Before Cataract Surgery?
This study checks whether treating dry eyes before cataract surgery can change the way your eye's shape (astigmatism) is measured. It may help make your surgery more accurate.
Shanghai, Shanghai MunicipalityAges Any age - NCT07657793RecruitingPhase 2/Phase 3
Sirolimus for Lupus-Related Low Platelets
This trial tests sirolimus, an immune-system-calming medicine, for people with lupus who also have very low platelet counts (ITP). It may help reduce bleeding risk and improve platelet numbers.
Beijing, Beijing MunicipalityAges 18–65 - NCT07658885Enrolling by invitation
AI snake identification for better bite treatment
This study tests a new AI system that uses photos of the snake to quickly identify the species and help doctors choose the right treatment. If you were bitten by a snake and have a clear picture of it, you may be able to join.
Hangzhou, ZhejiangAges 18–80 - NCT07655115RecruitingPhase 3
Arbaclofen for Autism: Brain Wave Study
This study tests a medicine called arbaclofen to see how it affects brain waves in people with autism. It includes a brief double-blind crossover phase followed by a 10-week open-label treatment period.
ParisAges birth–64 years
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.